Sofia de Achaval

536 total citations
13 papers, 406 citations indexed

About

Sofia de Achaval is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Sofia de Achaval has authored 13 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Sofia de Achaval's work include Lung Cancer Treatments and Mutations (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Medication Adherence and Compliance (3 papers). Sofia de Achaval is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Medication Adherence and Compliance (3 papers). Sofia de Achaval collaborates with scholars based in United States and Vietnam. Sofia de Achaval's co-authors include María E. Suarez‐Almazor, Vanessa Cox, Araceli García-González, Liana Fraenkel, Robert J. Volk, Marsha Richardson, John D. Reveille, H. Zhang, J. D. Reveille and Apostolia M. Tsimberidou and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and BMC Health Services Research.

In The Last Decade

Sofia de Achaval

13 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia de Achaval United States 9 179 85 79 70 44 13 406
Herman L. M. Brus Netherlands 9 318 1.8× 65 0.8× 37 0.5× 73 1.0× 21 0.5× 12 456
Antonio Aviña-Zubieta Canada 7 163 0.9× 29 0.3× 21 0.3× 28 0.4× 58 1.3× 16 377
Pongthorn Narongroeknawin Thailand 16 322 1.8× 30 0.4× 27 0.3× 38 0.5× 66 1.5× 42 617
Cianna Leatherwood United States 13 277 1.5× 23 0.3× 39 0.5× 17 0.2× 14 0.3× 22 508
Andrea Barbo United States 13 64 0.4× 11 0.1× 39 0.5× 17 0.2× 39 0.9× 19 434
Emily Durden United States 12 111 0.6× 24 0.3× 38 0.5× 6 0.1× 52 1.2× 25 455
Joel M. Hirsh United States 10 106 0.6× 16 0.2× 118 1.5× 21 0.3× 49 1.1× 19 355
Sadamu Okada Japan 9 35 0.2× 20 0.2× 19 0.2× 60 0.9× 28 0.6× 29 319
Abhishek Kavati United States 15 240 1.3× 18 0.2× 96 1.2× 141 2.0× 44 1.0× 50 890
Ruili Luo United States 9 45 0.3× 68 0.8× 34 0.4× 7 0.1× 79 1.8× 14 368

Countries citing papers authored by Sofia de Achaval

Since Specialization
Citations

This map shows the geographic impact of Sofia de Achaval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia de Achaval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia de Achaval more than expected).

Fields of papers citing papers by Sofia de Achaval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia de Achaval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia de Achaval. The network helps show where Sofia de Achaval may publish in the future.

Co-authorship network of co-authors of Sofia de Achaval

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia de Achaval. A scholar is included among the top collaborators of Sofia de Achaval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia de Achaval. Sofia de Achaval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tsimberidou, Apostolia M., David Vining, Sukeshi Patel Arora, et al.. (2025). Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 31(6). 965–974. 15 indexed citations
2.
Dayyani, Farshid, Marina Baretti, Sunyoung S. Lee, et al.. (2024). A phase 1b/2 study to evaluate the safety and efficacy of TTI-101 as monotherapy and in combination in advanced hepatocellular carcinoma.. Journal of Clinical Oncology. 42(3_suppl). TPS577–TPS577. 1 indexed citations
3.
Tsimberidou, Apostolia M., David Vining, Sukeshi Patel Arora, et al.. (2023). Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 3018–3018. 12 indexed citations
4.
Tsimberidou, Apostolia M., Sofia de Achaval, Imran Alibhai, & Ahmed O. Kaseb. (2021). First-in-man phase I clinical trial evaluating TTI-101, an orally bioavailable, small molecule inhibitor of STAT3, in patients with advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). TPS3158–TPS3158. 8 indexed citations
5.
Achaval, Sofia de. (2018). Long Term Assessment of Patient Treatment Preferences for Knee Osteoarthritis. DigtalCommons @ Texas Medical Center Library (Texas Medical Center). 1 indexed citations
6.
Achaval, Sofia de, Michael A. Kallen, Benjamin C. Amick, et al.. (2015). Patients' expectations about total knee arthroplasty outcomes. Health Expectations. 19(2). 299–308. 28 indexed citations
7.
Achaval, Sofia de, Michael A. Kallen, Maureen D. Mayes, María A. López-Olivo, & María E. Suarez‐Almazor. (2013). Use of the Patient-generated Index in Systemic Sclerosis to Assess Patient-centered Outcomes. The Journal of Rheumatology. 40(8). 1337–1343. 8 indexed citations
8.
Achaval, Sofia de, Vanessa Cox, Araceli García-González, et al.. (2013). Electronic Monitoring of Oral Therapies in Ethnically Diverse and Economically Disadvantaged Patients With Rheumatoid Arthritis: Consequences of Low Adherence. Arthritis & Rheumatism. 65(6). 1421–1429. 88 indexed citations
9.
Achaval, Sofia de, Chris Feudtner, Shana L. Palla, & María E. Suarez‐Almazor. (2013). Validation of ICD-9-CM codes for identification of acetaminophen-related emergency department visits in a large pediatric hospital. BMC Health Services Research. 13(1). 72–72. 16 indexed citations
10.
Achaval, Sofia de, et al.. (2012). Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring. Lupus. 21(11). 1158–1165. 66 indexed citations
11.
Achaval, Sofia de, Liana Fraenkel, Robert J. Volk, Vanessa Cox, & María E. Suarez‐Almazor. (2011). Impact of educational and patient decision aids on decisional conflict associated with total knee arthroplasty. Arthritis Care & Research. 64(2). 229–237. 73 indexed citations
12.
Achaval, Sofia de & María E. Suarez‐Almazor. (2010). Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International Journal of Clinical Rheumatology. 5(3). 313–326. 77 indexed citations
13.
Hwang, Jessica, et al.. (2009). Survival in cancer patients after out-of-hospital cardiac arrest. Supportive Care in Cancer. 18(1). 51–55. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026